BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 749979)

  • 21. Effect of pretreatment of rabbits with phenobarbital or 3-methylcholanthrene on the distribution of drug-metabolizing enzyme activity in subfractions of hepatic microsomes.
    Gram TE; Rogers LA; Fouts JR
    J Pharmacol Exp Ther; 1967 Aug; 157(2):435-45. PubMed ID: 6039834
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatic mixed-function oxidase activities of wild pigeons.
    Husain MM; Kumar A; Mukhtar H
    Xenobiotica; 1984 Oct; 14(10):761-6. PubMed ID: 6506750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of mixed-function oxidase inducers on the in vitro metabolism of N'-nitrosonornicotine by rat and hamster liver microsomes.
    McCoy GD; Chen CB; Hecht SS
    Drug Metab Dispos; 1981; 9(2):168-9. PubMed ID: 6113118
    [No Abstract]   [Full Text] [Related]  

  • 24. Biliary excretion of N,N-dimethyl-4-aminoazobenzene (DAB) in the rat. Effects of pretreatment with inducers and inhibitors of the mixed-function oxidase system and with agents that deplete liver glutathione.
    Levine WG; Finkelstein TT
    Drug Metab Dispos; 1978; 6(3):265-72. PubMed ID: 26547
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of sex and age on hepatic N-demethylation and hydroxylation reactions in phenobarbital induced rats.
    Patel JM; Pawar SS
    Indian J Med Res; 1973 Nov; 61(11):1666-71. PubMed ID: 4791512
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute interaction of drugs. I. The effect of volatile anesthetics on the kinetics of aniline hydroxylase and aminopyrine demethylase in rat hepatic microsomes.
    Korten K; Van Dyke RA
    Biochem Pharmacol; 1973 Sep; 22(17):2105-12. PubMed ID: 4733666
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of inducers and inhibitors of mixed-function oxidasts on benzo(a)pyrene binding to the DNA of rat liver nuclei.
    Alexandrov K; Thompson MH
    Cancer Res; 1977 May; 37(5):1443-9. PubMed ID: 856463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dantrolene inhibition of the hepatic mixed function oxidase system.
    Francis KT; Hamrick ME
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):69-80. PubMed ID: 441518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chronic administration of polybrominated biphenyls on parameters associated with hepatic drug metabolism.
    Dent JG; Netter KJ; Gibson JE
    Res Commun Chem Pathol Pharmacol; 1976 Jan; 13(1):75-82. PubMed ID: 1257602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposure of newborn rats to pharmacologically active compounds may permanently alter carcinogen metabolism.
    Faris RA; Campbell TC
    Science; 1981 Feb; 211(4483):719-21. PubMed ID: 7455708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species differences in stimulation of intestinal and hepatic microsomal mixed-function oxidase enzymes.
    Miranda CL; Chhabra RS
    Biochem Pharmacol; 1980 Apr; 29(8):1161-5. PubMed ID: 7387731
    [No Abstract]   [Full Text] [Related]  

  • 32. Different elimination and effect on mixed function oxidase of 20-methyl-cholanthrene after intragastric and intraperitoneal administration.
    Aitio A
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):701-10. PubMed ID: 4456502
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatic microsomal enzyme induction by 2,2', 3,3', 4,4'- and 2,2', 3', 4,4', 5-hexachlorobiphenyl.
    Parkinson A; Robertson LW; Safe S
    Life Sci; 1980 Dec; 27(24):2333-7. PubMed ID: 6782406
    [No Abstract]   [Full Text] [Related]  

  • 34. [The activity and inducibility of phenazone hydroxylases, amidopyrine-N and codeine-o-methylases in rat placenta during different periods in its functioning].
    Goffman G; Treger A; Bauman K; Kreĭsl' I
    Farmakol Toksikol; 1973; 26(4):457-60. PubMed ID: 4789897
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential induction of murine Ah locus-associated monooxygenase activities in rabbit liver and kidney.
    Atlas AS; Thorgeirsson SS; Boobis AR; Kumaki K; Nebert DW
    Biochem Pharmacol; 1975 Nov; 24(22):2111-6. PubMed ID: 1212260
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of linoleic acid hydroperoxide on the hepatic monooxygenase systems of microsomes from untreated, phenobarbital-treated, and 3-methylcholanthrene-treated rats.
    Jeffery E; Kotake A; Azhary RE
    Mol Pharmacol; 1977 May; 13(3):415-25. PubMed ID: 406515
    [No Abstract]   [Full Text] [Related]  

  • 37. The influence of some hepatic enzyme inducers and inhibitors on extrahepatic drug metabolism.
    Lake BG; Hopkins R; Chakraborty J; Bridges JW; Parke DV
    Drug Metab Dispos; 1973; 1(1):342-9. PubMed ID: 4149403
    [No Abstract]   [Full Text] [Related]  

  • 38. Species differences in the induction of microsomal hemoproteins and 3,4-benzpyrene hydroxylase by phenobarbital and 3-methylcholanthrene.
    Alvares AP; Schilling G; Levin W
    J Pharmacol Exp Ther; 1970 Oct; 175(1):4-11. PubMed ID: 5471452
    [No Abstract]   [Full Text] [Related]  

  • 39. Cholestasis as an in vivo model for analysis of the induction of liver microsomal monooxygenases by sodium phenobarbital and 3-methylcholanthrene.
    Tsyrlov IB; Polyakova NE; Gromova OA; Rivkind NB; Lyakhovich VV
    Biochem Pharmacol; 1979 May; 28(9):1473-8. PubMed ID: 475855
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of inducers and inhibitors of rat liver mono-oxygenases on digitoxin metabolism.
    Schmoldt A; Buhr SL; Albersmeyer K
    Biochem Pharmacol; 1980 Feb; 29(3):405-9. PubMed ID: 7362654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.